Resolution of Uremic Pericarditis after Living Donor Kidney Transplantation: A Case Report

Introduction: End-stage renal disease (ESRD) is a relevant metabolic cause for the onset of pericarditis and pericardial effusion. Uremic pericarditis has different therapeutic perspectives such as intensification of dialysis sessions, non-steroidal anti-inflammatory drugs, and corticosteroids (Systemic or Intrapericardial) or Pericardiocentesis. In patients with pericardial effusion and severe renal impairment colchicine, is contraindicated. Kidney transplantation is the treatment of choice for kidney failure and living donor kidney transplantation represents the best option in terms of graft function and longevity. Case Presentation: A 45-years-old Caucasian man with ESRD secondary to IgA glomerulonephritis, starting dialysis treatment in 2011. First kidney transplant in 07/04/2015. Following gradual worsening of kidney function. The echocardiographic checks were accompanied by a gradual increase in pericardial effusion, probably on uremic basis. Patient was admitted and started dialysis sessions and Pericardiocentesis, but the cardiac effusion reappeared. He underwent a living donor renal transplantation with good kidney function and at eight days following an echocardiogram was performed which showed the total disappearance of the effusion. Discussion: Our case appears to be the first report in literature of total and rapid resolution of uremic pericarditis with refractory pericardial effusion after living donor kidney transplantation, suggesting that the occurrence of uremic pericarditis should not delay transplantation when a living donor is available.

[1]  C. Asher,et al.  Uremic pericarditis, pericardial effusion, and constrictive pericarditis in end‐stage renal disease: Insights and pathophysiology , 2017, Clinical cardiology.

[2]  M. Haas,et al.  Assessment of Tocilizumab (Anti–Interleukin‐6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody‐Mediated Rejection and Transplant Glomerulopathy in HLA‐Sensitized Renal Allograft Recipients , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  M. Sarnak,et al.  Pericarditis and Pericardial Effusions in End‐Stage Renal Disease , 2016, Seminars in dialysis.

[4]  J. Squifflet,et al.  European Renal Best Practice Guideline on Kidney Donor and Recipient Evaluation and Perioperative Care , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  K. Swedberg,et al.  [2015 ESC Guidelines for the diagnosis and management of pericardial diseases]. , 2015, Kardiologia polska.

[6]  J. Pestana,et al.  Cardiovascular disease in early kidney transplantation: comparison between living and deceased donor recipients. , 2012, Transplantation proceedings.

[7]  V. Fuster,et al.  Cardiovascular risk factors in patients with chronic kidney disease , 2009, Nature Reviews Cardiology.

[8]  R. Pecoits-Filho,et al.  The Impact of Living Donor Kidney Transplantation on Markers of Cardiovascular Risk in Chronic Kidney Disease Patients , 2007, Blood Purification.

[9]  S. Sochocky Pericardial effusion. , 1968, Laval medical.